MDL | - |
---|---|
Molecular Weight | 441.50 |
Molecular Formula | C21H23N5O4S |
SMILES | O=C(C1=C(NC(N)=O)SC(C2=CC=C(C3=C(C)ON=C3C)C=C2O[C@@H]4CNCC4)=C1)N |
AZD3264 is a selective IkB-kinase IKK2 inhibitor.
IKK2 |
AZD3264 is a selective IkB-kinase IKK2 inhibitor, which is currently in preclinical development for the potential treatment of chronic pulmonary obstructive disorder (COPD) and asthma [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 48 mg/mL ( 108.72 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.2650 mL | 11.3250 mL | 22.6501 mL |
5 mM | 0.4530 mL | 2.2650 mL | 4.5300 mL |
10 mM | 0.2265 mL | 1.1325 mL | 2.2650 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (5.66 mM); Clear solution